FGEN
FibroGen Inc

4,831
Loading...
Loading...
News
all
press releases
Fibrogen Gets Regulator’s Green Light To Sell China Unit To AstraZeneca
The company expects the transaction, which was announced in February, to close in the third quarter of 2025.
Stocktwits·2mo ago
News Placeholder
More News
News Placeholder
FibroGen (FGEN) Reports Q2 Loss, Lags Revenue Estimates
FibroGen (FGEN) delivered earnings and revenue surprises of -50.22% and -53.52%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·2mo ago
News Placeholder
FibroGen (FGEN) Reports Q1 Loss, Tops Revenue Estimates
Zacks·5mo ago
News Placeholder
FibroGen Executives Depart Amid U.S. Operations Overhaul
The latest update is out from FibroGen ( ($FGEN) ). FibroGen, Inc. is streamlining its U.S. operations with a significant cost reduction strategy...
TipRanks Financial Blog·1y ago
News Placeholder
Pancreatic Cancer on the Rise: How Biotech Firms are Developing Groundbreaking Treatments
Pancreatic Cancer on the Rise: How Biotech Firms are Developing Groundbreaking Treatments Pancreatic Cancer on the Rise: How Biotech Firms are Developing Groundbreaking Treatments PR Newswire...
PR Newswire·1y ago
News Placeholder
FibroGen Stock Is Surging After The Bell: What's Going On?
FibroGen shares are moving higher in Monday's after-hours session after the company announced the FDA cleared its Investigational New Drug (IND) FG-3165. The company also announced a new clinical...
Benzinga·1y ago
News Placeholder
Biotech Advances in 2024: Innovative Treatments Aim to Boost Pancreatic Cancer Survival Rates
Biotech Advances in 2024: Innovative Treatments Aim to Boost Pancreatic Cancer Survival Rates Biotech Advances in 2024: Innovative Treatments Aim to Boost Pancreatic Cancer Survival Rates PR Newswire...
PR Newswire·1y ago
News Placeholder
FibroGen Shares Climb On Strong Q1 Sales
FibroGen reported quarterly losses of 33 cents per share which missed the analyst consensus estimate of $(0.31) and represents a 59.26% increase year-over-year. Quarterly sales clocked in at $55.902...
Benzinga·1y ago
News Placeholder
Notable Wednesday Option Activity: FGEN, PLCE, MDB
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in FibroGen Inc (FGEN), where a total volume of 13,026 contracts has been traded...
Stock Options Channel·2y ago
News Placeholder
Commit To Buy FibroGen At $1, Earn 44.2% Annualized Using Options
Investors eyeing a purchase of FibroGen Inc (FGEN) stock, but tentative about paying the going market price of 1.30/share, might benefit from considering selling puts among the alternative...
Stock Options Channel·2y ago

Latest FGEN News

View

Advertisement|Remove ads.

Advertisement|Remove ads.